About Vectura

We are a specialist inhalation CDMO that provides innovative inhaled drug development solutions to help customers bring their medicines to patients.

Our Science

See how our scientific innovation and expertise can support your inhaled development programme

Find out more

Product development

Tailored inhalation services for you

Track record

Choose a partner to help you succeed


Executive Changes at Vectura


On 31 March 2022, both Will Downie and Paul Fry stepped down from their respective roles as Chief Executive Officer...

Vectura wins Mediscience’s Best Communication Award


We are immensely proud to have been awarded Best Communication Award at the European Mediscience Awards. The judges concluded that...

Environmental, Social and Governance (ESG) Strategy

Know more about our commitment to creating long-term growth by embedding sustainability in all our business practices.